Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000947871-25-000305·Disc Medicine, Inc.
Schedule 13D ownership disclosure
Disc Medicine Inc
Common Stock · CUSIP: 254604101
Event date: 2025-03-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 1,556,369.00 · Class: 4.5%
- ORBIMED CAPITAL GP VI LLCReported CIK 0001682115
Shares: 530,487.00 · Class: 1.5%
- OrbiMed Capital GP VIII LLCReported CIK 0001845804
Shares: 820,707.00 · Class: 2.4%
- OrbiMed Genesis GP LLCReported CIK 0001808744
Shares: 205,175.00 · Class: 0.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000305
- Form type
- SCHEDULE 13D/A
- Filer
- Disc Medicine, Inc.
- CIK
- CIK 1816736
- Filed
- Mar 12, 2025
- Reporting period
- Mar 10, 2025
- Description
- Schedule 13D beneficial ownership